martes, 8 de octubre de 2019

Worth your time

D.C. Diagnosis
Nicholas Florko

Worth your time

The White House says drug prices are falling. But the index they used for this new report does not account for all medicines, including some newer and pricier drugs, STAT reports— Erin Mershon

Pharmaceutical companies are exploiting a gray area in U.S. immigration law and using payments as small as $20 to lure Mexican citizens across the border to donate their blood plasma, ProPublica reports, often putting their health at risk. — Lev Facher

Nevada's going to fine drug companies more than $17 million for failing to supply information required by a controversial state law. STAT's got the story. — Erin Mershon

The New York Times has a great rundown of the controversy surrounding the FDA’s approval of Descovy, the new PrEP drug from Gilead. — Nick Florko

No hay comentarios: